Gemini Health Partners Launches AI RCM Advisory Built on Real Adjudicated Claims Data for High-Cost Specialties

Advisory offering combines specialty operating experience with real adjudicated claims and prior authorization data across high-cost specialties to help healthcare organizations assess AI opportunities, develop investment priorities and plan implementation.

HOUSTON, Oct. 7, 2026 /PRNewswire/ -- Gemini Health Partners today announced its expansion into the healthcare advisory market with a dedicated focus on artificial intelligence strategy for high-cost specialty revenue cycle management (RCM). The practice supports private specialty clinics, hospitals and health systems in determining where AI and automation can address revenue cycle challenges, how technology should integrate with existing operations and how results should be measured. Organizations can engage Gemini for assessment and strategic guidance without outsourcing their billing department.

"An AI strategy for specialty revenue cycle management needs to start with how care is authorized, billed and paid," said Christopher Gonzalez, Chief Executive Officer of Gemini Health Partners. "Our team pairs clinical and reimbursement expertise with daily experience operating these exact specialty cycles. Because we perform this work ourselves, we can share what actually works, and we believe that openness is how the industry improves access to care. Our role is to help organizations set the right priorities, build a realistic business case and put the operating oversight in place to deliver on it."

AI strategy engagements assess data quality, workflow constraints and current systems before prioritizing use cases, from authorization workflows for complex radiation therapies and oncology drug reimbursement review to MRI and PET imaging medical-necessity checks and denial management. Gemini develops claims-informed business cases with assumptions stated explicitly, and supports technology architecture, vendor evaluation, governance and phased implementation with performance measures such as denial rates, authorization turnaround and cost to collect. Throughout, Gemini pairs a practical, hands-on approach to reimbursement with today's AI technology stack, maximizing reimbursement at a much lower enterprise cost than a traditional consulting engagement or a large in-house build. For organizations evaluating new clinical investments, the practice provides feasibility analysis for radiopharmaceutical therapy programs, PET and advanced imaging services, medical oncology program expansion, urology and new specialty centers.

A central element of the offering is Gemini's access to real adjudicated claims and prior authorization data from the specialty revenue cycles the firm operates, a depth of procedure-level detail in high-cost specialties that very few revenue cycle firms possess. The data spans proton therapy, radiation therapy, radiopharmaceutical therapy, medical oncology drug reimbursement, radiology procedures, MRI and PET scans, urology and orthopedics, and follows complex cases across their full lifecycle: initial authorization submissions, payer criteria applied, denials and their stated reasons, peer-to-peer and appeal outcomes, overturns and final payment behavior. Gemini's perspective is distinct because the firm's specialists bring both clinical and reimbursement backgrounds, and the cycles it advises on are the same cycles it operates daily. That operating knowledge is shared openly with clients and industry peers, on the conviction that transparency about what actually works is how high-cost specialty care becomes more accessible. Because the firm both operates these cycles and advises on them, Gemini models payer behavior, denial patterns and authorization outcomes from documented evidence rather than industry assumption. Projections are calibrated to each organization's payer mix, contracted rates and expected volumes, with assumptions and limitations documented.

Organizations seeking to review their current revenue cycle or evaluate a new program can learn more at https://geminihealthpartners.com/advisory. The firm's claims-based projection methodology is described at https://geminihealthpartners.com/claims-data.

About Gemini Health Partners

Gemini Health Partners is a Houston-based healthcare revenue cycle management and advisory firm serving high-cost medical specialties across the United States. Its services span specialty RCM AI strategy, revenue cycle assessment, new-program feasibility, technology architecture and implementation support, prior authorization and end-to-end revenue cycle operations.

Media Contact
Gemini Health Partners
20405 TX-249, Chasewood, Houston, Texas 77070
[email protected]
281-686-5846
https://geminihealthpartners.com/advisory

SOURCE Gemini Health Partners